Article

Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients

2022-11-03

Abstract excerpt

COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), is estimated to have caused over 6.5 million deaths to date worldwide. The emergence of fast-evolving SARS-CoV-2 variants of concern alongside increased transmissibility and/or virulence as well as immune and vaccine escape capabilities highlight the urgent need for more effective antivirals to combat the disease in the long run...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7acfd267-0d9d-5df3-908e-e1934b79a3b3
DOI: 10.20944/preprints202211.0075.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Use of Antiandrogens as Therapeutic Agents in COVID-19 PatientsDOI 10.20944/preprints202211.0075.v1Read

Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in MenSemantic proximity Read

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cellsSemantic proximity Read

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19Semantic proximity Read

Reciprocally Divergent Levels of Testosterone and Dihydrotestosterone Accompany Patterns of Androgen Receptor Pathway Signaling to Dictate COVID-19 Outcomes in MenSemantic proximity Read

The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronavirusesSemantic proximity Read

Review of COVID‐19 and male genital tractSemantic proximity Read

TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?Semantic proximity Read

Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.Semantic proximity Read

An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female TrialSemantic proximity Read

Is COVID-19 Gender-sensitive?Semantic proximity Read

Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19Semantic proximity Read

COVID-19 and Male Reproduction: A Thorny ProblemSemantic proximity Read